US Weekly 24.8.2026
brief · 2026-08-24 · AI, energy, healthcare · 1–2 weeks
§01 · Macro snapshot
| Indicator | Latest | Prior | Change | As of |
|---|---|---|---|---|
| 10Y–2Y spread (pp) | 0.50 | 0.51 | –0.01 | 2026-08-21 |
| 10Y–3M spread (pp) | 0.86 | 0.82 | +0.04 | 2026-08-21 |
| HY OAS (pp) | 2.75 | 2.71 | +0.04 | 2026-08-20 |
| Unemployment (U3, %) | 4.1 | 4.2 | –0.1 | 2026-07-01 |
| Initial jobless claims | 206,000 | 212,000 | –6,000 | 2026-08-15 |
| Sahm rule indicator | –0.03 | +0.07 | –0.10 | 2026-07-01 |
Source: FRED (St Louis Fed). The Sahm-rule step below zero is the standout — see the catch at the end of §02.
§02 · Themes of the week
AI complex trims into the NVDA print
NVIDIA reports later this week. Coverage in the packet centres the event on a headline ~$92B figure that will "make or break the AI trade" (packet does not disambiguate revenue vs. bottom-line — treat as the print, not a specific line item). Ahead of it, the AI-heavy names faded together — XLK –3.53%, NVDA –4.64%, MSFT –2.45%, META –6.77% — while breadth held elsewhere (SPY –1.37%, IWM –1.68%, DIA –0.77%).
The interesting split sits inside the AI complex itself. MSFT is the one megacap whose industry trend still marks RISING, and it has run +26.64% in a month with a 13-week RS versus SPY of +12.13. AAPL, NVDA, GOOGL, AMZN and META all sit under a DEGRADING industry-trend label. The reshuffle looks like money staying inside AI, not leaving it — MSFT gaining share on the back of the OpenAI-independence storyline (Nadella's "up to 40%" efficiency-gain comments on Microsoft's own AI chips, the AMD tie-up) while the rest thin.
Counter-thesis: the DEGRADING labels reflect prior-period tape, not an active topping process. NVDA above 200d and 30w with RSI 59 into a binary print is a normal-course setup, not distribution.
This would be wrong if NVDA prints in line but guidance is materially soft AND MSFT gives back a meaningful piece of its 26% monthly gain. That combination would say the intra-complex rotation was masking capex fatigue across the whole group, not funding a new leader.
Sources: Bloomberg, Financial Times, MarketWatch, Nikkei Asia, The Information.
Ormuz reflexivity is back in the tape
The packet carries three pieces that only make sense read together: a Le Journal du Dimanche/MSN report (French-language, single-source tier3) that the US is running a "covert oil transport operation" through the Strait of Hormuz; a Bluesky post citing a Reuters/apple.news item on Iran threatening to halt all oil exports (the "economic D-Day" language — the Reuters article itself is not in the packet, only the social citation); and Oman's foreign minister traveling to Tehran on Tuesday. That last one is the de-escalation channel switching on.
Prices moved: XLE +2.79% on the week (RSI 75.4 — the sector is stretched), XOM +3.79% (RSI 67.6, industry trend RISING, one-year +55.51%). XOM is also named in the Shell US chemicals suitor list — Bloomberg has XOM and Apollo; a separate FT-cited item names XOM and LyondellBasell. So there is inorganic activity around XOM on top of crude beta.
Counter-thesis: Hormuz theatrics have been priced and re-priced repeatedly this year without ever producing an actual closure. The Oman visit says both sides are still in the room. This week's move is the familiar spike-then-fade.
This would be wrong if the Oman channel yields no communiqué inside five trading days AND XOM breaks above the 52-week high with the Shell chemicals process advancing to a named bidder — that combination shifts the read from geopolitical beta to company-specific expansion.
Sources: Al-Monitor, Bloomberg, Financial Times, Le Journal du Dimanche, Bluesky.
Healthcare bid, with a divergence worth reading
XLV +4.33% on the week (RSI 77 — overbought), LLY +6.38% (RSI 69.5, industry trend PEAKING, one-year +78.82%). The near-term LLY story visible in this week's tape is the ongoing GLP-1 competitive dynamic with Novo Nordisk (packet: "Novo claws its way back into race with Lilly"). A prior olomorasib FDA breakthrough item sits in ma_news but is dated August 8, outside the W35 window.
The tell is UNH. Managed care did NOT participate — UNH –2.89% on the week, RSI 31.4, industry trend DEGRADING, four-week RS versus SPY –10.52. In a broad defensive rotation, UNH bids too. It didn't. So what looks like healthcare-as-defense is actually a narrow drug-manufacturer bid — pipeline names, not the sector as shelter.
Counter-thesis: RSI 77 in XLV is a low-volume August artifact; UNH catches up next week when institutional flow returns and the divergence closes.
This would be wrong if UNH regains 4% inside ten trading days AND LLY's RSI stays above 65 — that combination validates the broad-rotation read and invalidates the narrow-pipeline read.
Sources: Bloomberg, The Japan Times.
The catch ▸ Sahm rule flipped to –0.03 while claims fell to 206k
The Sahm-rule indicator printed –0.03 for July, down from +0.07 the prior month — a 10bp step that takes the recession-tell BELOW zero. Initial claims fell 6,000 to 206,000 the same week. U3 dropped a tenth to 4.1%. The narrative most rate-cut framings have anchored to (a labor market softening toward the Sahm trigger) is now moving in the opposite direction. Watch how this reads into Jackson Hole language and the September 4 payrolls print — the labor-side case for pre-emptive easing just weakened, quietly.
§03 · Companies of interest
Research surface — not investment advice.
| Name | Exchange | Sector | Theme link | Technical snapshot |
|---|---|---|---|---|
| XLK (Technology Select ETF) | US | Technology | AI complex faded into NVDA | $183.31, above 200d/30w, RSI 59.4, –3.53% wk, +30.12% 6m |
| NVDA (NVIDIA) | US | Semiconductors | Binary print this week sets the AI-trade tone | $214.72, above 200d/30w, RSI 59.5, –4.64% wk. Industry trend DEGRADING. Recent ma_news is NVDA-as-acquirer (Cloverleaf, Decart bidding race, ~$6B China initiative) — capex sprawl, not a target situation. Merger-arb frame does not apply |
| MSFT (Microsoft) | US | Software | The AI megacap whose industry trend still marks RISING | $483.24, above 200d/30w, RSI 47, –2.45% wk but +26.64% 1m. 13w RS vs SPY +12.13 — notable relative outperformance inside the complex |
| META (Meta Platforms) | US | Communication Services | Sharp –6.77% week; the AI standout on the wrong side of trend | $549.90, BELOW 200d and 30w, RSI 31.3, –26.28% 1y. Named driver in packet: Nikkei report on China tightening border crossings after Meta's move for AI startup Manus — treat as AI-M&A strategy risk, not tape noise. Bid/consortium activity flagged in ma_news |
| XLE (Energy Select ETF) | US | Energy | Hormuz beta plus consortium activity in Shell chemicals | $63.64, above 200d/30w, RSI 75.4 (overbought), +2.79% wk, one-year +50.9%. Read as geopolitical-headline beta |
| XOM (Exxon Mobil) | US | Oil & Gas Integrated | Named suitor for Shell US chemicals; direct Ormuz exposure | $165.11, above 200d/30w, RSI 67.6, +3.79% wk, +55.51% 1y. Industry trend RISING. Two FT-cited items place XOM in the Shell chemicals suitor group (with Apollo per Bloomberg; with LyondellBasell separately) — M&A activity sits alongside the crude tape |
| LLY (Eli Lilly) | US | Drug Manufacturers | Sharp +6.38% week during a broader healthcare bid | $1,255, above 200d/30w, RSI 69.5, +78.82% 1y. Industry trend PEAKING. In-window driver: ongoing GLP-1 competitive dynamic with Novo Nordisk (Japan Times). Olomorasib FDA breakthrough item is dated Aug 8 and predates the W35 window |
| UNH (UnitedHealth) | US | Healthcare Plans | Divergence tell: oversold while sector rips | $390.11, above 200d/30w, RSI 31.4, –2.89% wk. 4w RS vs SPY –10.52. Industry trend DEGRADING. Managed-care sitting out a healthcare bid is the read to track |
| KKR (KKR & Co) | US | Asset Management | Active acquirer this week — UGI bid, $5.51B Steadfast, DCC Energy | $108.48, above 200d/30w, RSI 52.6, –4.85% wk but +13.04% 1m. Industry trend RISING. Multiple pending transactions surface in the packet — technicals partly reflect deal-pipeline execution risk |
Technicals: market data, computed 2026-08-24 06:08 UTC.
§04 · Calendar ahead
- 2026-09-04 (Thu) — US Non-Farm Payrolls. First payrolls print after the Sahm-rule flip to –0.03. A second consecutive strong reading changes the rate-cut framing materially.
§05 · Methodology + disclaimer
Macro series from FRED (St Louis Fed). Market technicals computed 2026-08-24 06:08 UTC. News from an aggregated corpus (Bloomberg, FT, Reuters citations, Nikkei Asia, Al-Monitor, MarketWatch, tiingo feeds, GNews); single-source and tier3 items flagged where the read hinges on them. Research material, not investment advice.
2026-08-24 · brief v.2